Patents by Inventor Mark Travi
Mark Travi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11554137Abstract: A composition and method useful in promoting healing of a bleeding wound site. The composition preferably includes a substantially anhydrous acid form of a cation exchange resin, which when applied over blood, provides an antimicrobial against planktonic microorganisms and biofilms in the wound. The resin is also capable, when applied in sufficient quantities, of providing a continuing and persistent antimicrobial against planktonic microorganisms and biofilms through dehydration and ion exchange with cations present in the blood and other body fluids. When the resin has a concentration of at least 26 mg/ml, it provides a >3 log reduction in biological activity of MRSA, MRSE and Pseudomonas aeruginosa.Type: GrantFiled: January 3, 2014Date of Patent: January 17, 2023Assignee: Biolife, L.L.C.Inventors: John Hen, John Alfred Thompson, Talmadge Kelly Keene, Mark Travi
-
Publication number: 20220192891Abstract: A flexible hemostatic pad formed from a hemostatic powder, which may contain a hydrophilic polymer such as a cation ion exchange resin, compressed onto or into a velvet-like backing substrate is provided for the control of bleeding at a wound site.Type: ApplicationFiled: February 4, 2021Publication date: June 23, 2022Inventors: Kurt Vadelund, Talmadge Kelly Keene, Kenneth Wiglund, Mark Travi
-
Publication number: 20220151930Abstract: A wound sealing powder, method of making a wound sealing powder, and method of using a wound sealing powder to reduce blood flow from a wound are provided. Specifically, the wound sealing powder utilizes a particulate powder material of an effective amount of an insoluble cation exchange material wherein the majority of the particles in the powder have particle sizes of less than approximately 48 microns.Type: ApplicationFiled: December 30, 2021Publication date: May 19, 2022Inventors: Kurt Vadelund, Talmadge Kelly Keene, Mark Travi
-
Patent number: 11241386Abstract: A wound sealing powder, method of making a wound sealing powder, and method of using a wound sealing powder to reduce blood flow from a wound are provided. Specifically, the wound sealing powder utilizes a particulate powder material of an effective amount of an insoluble cation exchange material wherein the majority of the particles in the powder have particle sizes of less than approximately 48 microns.Type: GrantFiled: February 13, 2019Date of Patent: February 8, 2022Assignee: Biolife, L.L.C.Inventors: Kurt Vadelund, Talmadge Kelly Keene, Mark Travi
-
Publication number: 20200253874Abstract: A wound sealing powder, method of making a wound sealing powder, and method of using a wound sealing powder to reduce blood flow from a wound are provided. Specifically, the wound sealing powder utilizes a particulate powder material of an effective amount of an insoluble cation exchange material wherein the majority of the particles in the powder have particle sizes of less than approximately 48 microns.Type: ApplicationFiled: February 13, 2019Publication date: August 13, 2020Inventors: Kurt Vadelund, Kelly Keene, Mark Travi
-
Patent number: 9928627Abstract: An approach is provided for grouping and de-overlapping items in a user interface. A display manager determines one or more items for rendering in a user interface. The display manager then causes, at least in part, a determination of one or more rendering locations for one or more representations of the one or more items based, at least in part, on location information associated with the one or more items. The display manager further causes, at least in part, a grouping, a de-overlapping, or a combination thereof of the one or more representations based, at least in part, on an overlapping of the one or more rendering locations. The display manager also causes, at least in part, a rendering of the one or more representations in the user interface based, at least in part, on the grouping, the de-overlapping, or a combination thereof.Type: GrantFiled: June 17, 2015Date of Patent: March 27, 2018Assignee: Nokia Technologies OyInventors: Mark Travis Fulks, Ashok Ravula, Kenneth Walker, Bamidele Adetokunbo, Srikanth Challa, Christophe Marle, Aaron Licata, Pankaj Kumar Jain, Matthew Johnson
-
Patent number: 9877728Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.Type: GrantFiled: March 2, 2017Date of Patent: January 30, 2018Assignee: Biolife, L.L.C.Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
-
Patent number: 9827409Abstract: A tattooing device is designed for ingraining a design on the skin. The tattooing device includes an electric drive motor with a rotatable motor pin. The motor pin defines an axis of rotation. A rotatable actuator cam is operatively connected to the motor pin, and comprises a cam post axially offset from the motor pin and the axis of rotation. An elongated drive shaft is operatively connected to the cam post, such that rotation of the actuator cam effects simultaneous substantially linear reciprocating movement of the drive shaft. A needle assembly is operatively connected to the drive shaft, and adapted for carrying a pointed tattooing needle for penetrating the skin.Type: GrantFiled: February 6, 2015Date of Patent: November 28, 2017Assignee: Inline Tattoo Machines, LLCInventors: Mark Travis Evans, Grady Lee Dudding, Jr.
-
Publication number: 20170172582Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.Type: ApplicationFiled: March 2, 2017Publication date: June 22, 2017Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
-
Patent number: 9585671Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.Type: GrantFiled: May 21, 2015Date of Patent: March 7, 2017Assignee: Biolife, L.L.C.Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
-
Publication number: 20160206298Abstract: A combination radial arm band and hemostatic material preferably including potassium ferrate and a cation ion exchange resin in powder or granular form (WOUNDSEAL) or formed into a solid tablet (STATSEAL) and having improved topical effectiveness in the arresting of blood flow from a puncture wound into the radial artery made during transradial diagnostic or interventional catheterization procedures. The combination reduces time and pressure needed to achieve hemostasis and decreases arterial damage as compared to use of a radial arm band alone. In one aspect of this disclosure, careful limitation of applied force and time of applied force against the STATSEAL tablet reduces likelihood of harm to the radial artery while minimizing time to achieve hemostasis.Type: ApplicationFiled: January 21, 2016Publication date: July 21, 2016Inventors: Talmadge Kelly Keene, Timothy J. Kelly, John Tifton Fordham, Mark Travi
-
Patent number: 9245051Abstract: An approach is provided for conducting a search based on an extraction of a search term from available sensor data. The approach involves determining sensor data associated with at least one device, the sensor data determined from among a plurality of available data modes. The approach also involved processing and/or facilitating a processing of the sensor data to cause, at least in part, an extraction of one or more search terms for at least one query. The approach further involves determining one or more results of the at least one query based, at least in part, on context information associated with the at least one device, user profile information associated with the at least one device, or a combination thereof.Type: GrantFiled: September 20, 2011Date of Patent: January 26, 2016Assignee: NOKIA TECHNOLOGIES OYInventors: Aaron Licata, Adetokunbo Bamidele, Mark Travis Fulks
-
Publication number: 20150356763Abstract: An approach is provided for grouping and de-overlapping items in a user interface. A display manager determines one or more items for rendering in a user interface. The display manager then causes, at least in part, a determination of one or more rendering locations for one or more representations of the one or more items based, at least in part, on location information associated with the one or more items. The display manager further causes, at least in part, a grouping, a de-overlapping, or a combination thereof of the one or more representations based, at least in part, on an overlapping of the one or more rendering locations. The display manager also causes, at least in part, a rendering of the one or more representations in the user interface based, at least in part, on the grouping, the de-overlapping, or a combination thereof.Type: ApplicationFiled: June 17, 2015Publication date: December 10, 2015Inventors: Mark Travis FULKS, Ashok RAVULA, Kenneth WALKER, Bamidele ADETOKUNBO, Srikanth CHALLA, Christophe MARLE, Aaron LICATA, Pankaj Kumar JAIN, Matthew JOHNSON
-
Publication number: 20150257766Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.Type: ApplicationFiled: May 21, 2015Publication date: September 17, 2015Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
-
Patent number: 9087412Abstract: An approach is provided for grouping and de-overlapping items in a user interface. A display manager determines one or more items for rendering in a user interface. The display manager then causes, at least in part, a determination of one or more rendering locations for one or more representations of the one or more items based, at least in part, on location information associated with the one or more items. The display manager further causes, at least in part, a grouping, a de-overlapping, or a combination thereof of the one or more representations based, at least in part, on an overlapping of the one or more rendering locations. The display manager also causes, at least in part, a rendering of the one or more representations in the user interface based, at least in part, on the grouping, the de-overlapping, or a combination thereof.Type: GrantFiled: September 14, 2012Date of Patent: July 21, 2015Assignee: NOKIA TECHNOLOGIES OYInventors: Mark Travis Fulks, Ashok Ravula, Kenneth Walker, Bamidele Adetokunbo, Srikanth Challa, Christophe Marle, Aaron Licata, Pankaj Jain, Matthew Johnson
-
Publication number: 20150147392Abstract: A method of arresting blood flow from a bleeding wound including the steps of (1) providing a solid hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery onto a bleeding wound, the tablet defining a proximal portion and a distal portion, (2) applying the proximal portion against the bleeding wound to improve the rate of adhesion to a bleeding wound surface, and then (3) applying pressure against the tablet over the wound site. After the seal is formed from the interaction of blood or exudates with the proximal portion of the tablet, the distal portion of the tablet delaminates from the proximal portion to form a reservoir to stop further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.Type: ApplicationFiled: January 27, 2015Publication date: May 28, 2015Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
-
Patent number: 9039667Abstract: A method of arresting blood flow from a bleeding wound including the steps of (1) providing a solid hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery onto a bleeding wound, the tablet defining a proximal portion and a distal portion, (2) applying the proximal portion against the bleeding wound to improve the rate of adhesion to a bleeding wound surface, and then (3) applying pressure against the tablet over the wound site. After the seal is formed from the interaction of blood or exudates with the proximal portion of the tablet, the distal portion of the tablet delaminates from the proximal portion to form a reservoir to stop further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.Type: GrantFiled: January 27, 2015Date of Patent: May 26, 2015Assignee: Biolife, L.L.C.Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
-
Patent number: 8979726Abstract: A composition and method of arresting the flow of blood from a bleeding wound. The composition preferably includes an anhydrous salt ferrate compound preferably combined with an effective amount of an insoluble cation exchange material and an effective amount of anhydrous Magnetite mixed uniformly together. Povidone iodine may be added for enhanced antimicrobial properties. In the method, a quantity of the composition is magnetically attached to a surface of a magnet, after which the powderous mixture is applied to the wound by pressing the surface covered with the powderous compound against the wound for a time sufficient to clot the blood to arrest substantial further blood flow from the wound.Type: GrantFiled: February 6, 2013Date of Patent: March 17, 2015Assignee: Biolife, L.L.C.Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
-
Patent number: 8961479Abstract: A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion to a bleeding wound surface, and allows a significantly greater and more uniform pressure to be exerted by manual compression of the tablet on the wound site, as compared to that of a thin layer of scattered hemostatic powder. After the seal is formed from the interaction of blood or exudates with the immediate contacting surface of the tablet, the bulk of the unused tablet easily delaminates from the seal making clean up facile. If the unused portion of the tablet is not removed from the wound site, a reservoir of hemostatic dressing stops further bleeding and to provide antimicrobial protection and healing. The tablet may be applied to any surface orientation and take any shape and thickness possible.Type: GrantFiled: March 19, 2013Date of Patent: February 24, 2015Assignee: Biolife, L.L.C.Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
-
Publication number: 20140120052Abstract: A composition and method useful in promoting healing of a bleeding wound site. The composition preferably includes a substantially anhydrous acid form of a cation exchange resin, which when applied over blood, provides an antimicrobial against planktonic microorganisms and biofilms in the wound. The resin is also capable, when applied in sufficient quantities, of providing a continuing and persistent antimicrobial against planktonic microorganisms and biofilms through dehydration and ion exchange with cations present in the blood and other body fluids. When the resin has a concentration of at least 26 mg/ml, it provides a >3 log reduction in biological activity of MRSA, MRSE and Pseudomonas aeruginosa.Type: ApplicationFiled: January 3, 2014Publication date: May 1, 2014Applicant: BIOLIFE, LLCInventors: JOHN HEN, JOHN ALFRED THOMPSON, TALMADGE KELLY KEENE, MARK TRAVI